Select the drug indication to add to your list


Digestive and biliary disorders
Only 4 drugs may be compared at once

Generic Name and Formulations:

Lipase/protease/amylase: 10440Units/39150Units/39150Units; 20880Units/78300Units/78300Units; tabs.



Select therapeutic use:

Indications for VIOKACE:

Treatment of exocrine pancreatic insufficiency in adults due to chronic pancreatitis or pancreatectomy, in combination with a proton pump inhibitor.


See literature. Start at the lowest recommended dose and increase gradually. Individualize based on clinical symptoms, the degree of steatorrhea present, and the fat content of the diet. Swallow whole; do not crush or chew tabs. Do not allow drug to remain in mouth. Initially 500 lipase units/kg per meal. Max: 2500 lipase units/kg per meal (or ≤10000 lipase units/kg per day), or <4000 lipase units/g fat ingested per day.


Not established.


Not interchangeable with any other pancrelipase products. Fibrosing colonopathy (with high doses); risk of stricture formation (monitor). Pork allergy. Potential viral transmission. Gout. Renal impairment. Hyperuricemia. Contents irritating to mucosa. Lactose intolerance. Pregnancy (Cat.C). Nursing mothers.

Pharmacological Class:

Pancreatic enzymes (porcine).

Adverse Reactions:

Biliary tract stones, anal pruritus; fibrosing colonopathy, hyperuricemia, allergic reactions.

How Supplied:


VIOKACE 10440 units tablets (Qty:270)

appx. price $869.00